According to the study conducted by Zhang and colleagues, MALAT-1 expression was elevated in CRC patients, and it exhibited correlations with a poorer prognosis, lymph node metastases, and an advanced TNM stage. Here, MALAT1 is linked to colorectal carcinoma.